GEN Exclusives

More »

GEN News Highlights

More »
Aug 11, 2010

ACT Secures More Resources to Advance Cancer Programs

  • Advanced Cancer Therapeutics (ACT) inked an exclusive agreement with Jason Chesney, M.D., Ph.D., associate professor in the department of medicine at the University of Louisville’s James Graham Brown Cancer Center. Dr. Chesney, who signed a two-year contract, will work to identify new clinical candidates against two key cancer metabolic targets for the prevention and treatment the disease.

    Dr. Chesney is the second University of Louisville researcher to sign on to work with ACT to accelerate development of its two top programs. John Trent, associate professor in the department of medicine at the James Graham Brown Cancer Center, was contracted by the firm in February.

    Both researchers will work with ACT to further refine and advance the preclinical candidates and back-up compounds against 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 (PFKFB3) and choline kinase (CK). Drs. Chesney and Trent and two other Brown Cancer Center scientists recently unveiled the role of choline kinase in the survival of tumors. IP covering these discoveries was was licensed to ACT in June 2009.

    ACT was founded in 2007 to serve as a conduit for new cancer drugs, technologies, and other therapies developed at the University of Louisville. At the time of its formation, the university owned 30% of the company. In July of this year, ACT reported raising $10 million to advance its portfolio of technologies and product candidates.

Add a comment

  • You must be signed in to perform this action.
    Click here to Login or Register for free.
    You will be taken back to your selected item after Login/Registration.

Related content


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

Easing Restrictions for Terminal Patients

Should the Federal Government Pass a “Right to Try” Bill Allowing Terminally Ill Patients Access to Experimental Medicines?

More »